Top Story

Vaxess' Rachel Sha - 'own the seat at the table that you have and have confidence'

Vaxess' Rachel Sha - 'own the seat at the table that you have and have confidence'

19-Nov-2024

|

By Liza Laws

Editor's Choice

Women in Science - Emmanuelle Cameau on growing stronger from challenges

Women in Science - Emmanuelle Cameau on growing stronger from challenges

19-Nov-2024

|

By Liza Laws

Headlines

uMotif expands site and patient platform with ClinOne acquisition

F2G raises $100 million to combat innovation 'paucity' in antifungals

Boehringer Ingelheim score with phase 3 idiopathic pulmonary...

Women in science - Alison O'Neill at YPrime on thinking out loud and...

NuraBio closes $140m fundraising to develop neuroprotective drugs

Insilico Medicine claims phase 2 win for AI-designed drug

→

In focus

The intersection of ethics and AI in healthtech marketing: Insights from ObvioHealth

19-Nov-2024 By Liza Laws

Streamlining early phase drug development with continuous flow technologies

Paid for and in partnership with Lonza Small Molecules

How early utilisation of AI can de-risk and accelerate clinical development

19-Nov-2024 By Liza Laws

Achieving data integrity: Best practices for secure and reliable data management

Paid for and content provided by METTLER TOLEDO

Featured

Insight

Innovative approaches to opioid use disorder treatment

By Liza Laws

Innovative approaches to opioid use disorder treatment

Clinical trials & development

→

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

21-Nov-2024

By Helen Albert

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Partner insightMore →

Powered by Ingredients + Innovation

Content provided by Univar Solutions USA

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd.

Accurate determination of resin substitution in solid phase peptide synthesis

Content provided by Almac Group

Reliability, scale, and security of supply

Content provided by Univar Solutions USA

Markets & regulatory news

→

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

15-Nov-2024

By Liza Laws

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Gifthealth and United Digestive partner for enhanced GI care access

Gifthealth and United Digestive partner for enhanced GI care access

12-Nov-2024

By Liza Laws

Drug delivery & innovation

→

Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease

Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease

19-Nov-2024

By Larissa Warneck-Silvestrin

Overcoming nonspecific binding challenges in pharmacokinetic assays

Overcoming nonspecific binding challenges in pharmacokinetic assays

14-Nov-2024

By Liza Laws

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

08-Nov-2024

By Liza Laws

Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist

Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist

07-Nov-2024

By Clara Rodriguez Fernandez

Expand your knowledge

Industry Newsletters

Choose from regular, topic-based and special edition briefings

Resource centre

Discover cutting edge insight from our partners

Events & webinars

Explore our programme of live & on-demand content